Cite
HARVARD Citation
Gerson-Gurwitz, A. et al. (n.d.). Dissection of cancer therapy combinations in RTK driven tumors using zotatifin (eFT226), a potent and selective eIF4A inhibitor. European journal of cancer. pp. S56-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gerson-Gurwitz, A. et al. (n.d.). Dissection of cancer therapy combinations in RTK driven tumors using zotatifin (eFT226), a potent and selective eIF4A inhibitor. European journal of cancer. pp. S56-. [Online].